首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   62546篇
  免费   4954篇
  国内免费   1833篇
耳鼻咽喉   829篇
儿科学   1186篇
妇产科学   2215篇
基础医学   7921篇
口腔科学   1167篇
临床医学   6756篇
内科学   11533篇
皮肤病学   1188篇
神经病学   3893篇
特种医学   2623篇
外国民族医学   6篇
外科学   8468篇
综合类   4192篇
现状与发展   7篇
一般理论   11篇
预防医学   3342篇
眼科学   1389篇
药学   5359篇
  19篇
中国医学   1666篇
肿瘤学   5563篇
  2023年   461篇
  2022年   583篇
  2021年   1891篇
  2020年   1294篇
  2019年   1613篇
  2018年   1998篇
  2017年   1516篇
  2016年   1567篇
  2015年   2332篇
  2014年   2915篇
  2013年   3403篇
  2012年   4818篇
  2011年   4695篇
  2010年   2987篇
  2009年   2616篇
  2008年   3544篇
  2007年   3637篇
  2006年   3393篇
  2005年   3136篇
  2004年   2825篇
  2003年   2706篇
  2002年   2347篇
  2001年   1850篇
  2000年   1607篇
  1999年   1326篇
  1998年   518篇
  1997年   426篇
  1996年   404篇
  1995年   377篇
  1994年   357篇
  1993年   256篇
  1992年   716篇
  1991年   599篇
  1990年   537篇
  1989年   496篇
  1988年   423篇
  1987年   423篇
  1986年   357篇
  1985年   297篇
  1984年   229篇
  1983年   193篇
  1982年   113篇
  1981年   123篇
  1980年   100篇
  1979年   206篇
  1978年   162篇
  1977年   103篇
  1976年   110篇
  1975年   101篇
  1974年   99篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
目的 探讨儿童急性磷化氢中毒的临床特点,及大剂量细胞色素C的临床作用。方法 收集2013年11月—2018年6月本中心救治的急性磷化氢中毒儿童22例临床资料,并回顾性分析。结果 男13例,女9例;年龄29 d~13岁;轻中度磷化氢中毒10例,重度磷化氢中毒12例;轻中度中毒患儿出现症状至就诊时间明显短于重度中毒患儿(P=0.029)。轻中度磷化氢中毒主要表现为头晕、恶心、呕吐、腹痛;重度中毒主要表现为昏迷、口唇紫绀、低血压,甚至心源性休克。实验室检查:脑钠肽异常升高12例;心肌酶异常12例;血乳酸升高10例;心电图异常16例,均表现为快速心律失常,其中1例为尖端扭转型心律失常。除常规治疗外,均给予大剂量细胞色素C治疗,轻中度中毒患儿均治愈,重度中毒患儿治愈6例,死亡6例,22例儿童磷化氢中毒总死亡率为27.3%,重度磷化氢中毒死亡率50%。结论 儿童急性磷化氢中毒死亡率高,在常规治疗的基础上,给予静脉应用大剂量细胞色素C可明显降低儿童急性磷化氢中毒的死亡率。  相似文献   
42.
Neurocritical Care - The Neurocritical Care Society and the Society of Critical Care Medicine have worked together to create a perspective regarding the Standards of Neurologic Critical Care Units...  相似文献   
43.
44.
Background and purpose — The COVID-19 pandemic has been recognized as an unprecedented global health crisis. This is the first observational study to evaluate its impact on the orthopedic workload in a London level 1 trauma center (i.e., a major trauma center [MTC]) before (2019) and during (2020) the “golden month” post-COVID-19 lockdown.Patients and methods — We performed a longitudinal observational prevalence study of both acute orthopedic trauma referrals, operative and anesthetic casemix for the first “golden” month from March 17, 2020. We compared the data with the same period in 2019. Statistical analyses included median (median absolute deviation), risk and odds ratios, as well as Fisher’s exact test to calculate the statistical significance, set at p ≤ 0.05.Results — Acute trauma referrals in the post-COVID period were almost halved compared with 2019, with similar distribution between pediatric and adult patients, requiring a significant 19% more admissions (RR 1.3, OR 2.6, p = 0.003). Hip fractures and polytrauma cases accounted for an additional 11% of the modal number of injuries in 2020, but with 19% reduction in isolated limb injuries that were modal in 2019. Total operative cases fell by a third during the COVID-19 outbreak. There was a decrease of 14% (RR 0.85, OR 0.20, p = 0.006) in aerosol-generating anesthetic techniques used.Interpretation — The impact of the COVID-19 pandemic has led to a decline in the number of acute trauma referrals, admissions (but increased risk and odds ratio), operations, and aerosolizing anesthetic procedures since implementing social distancing and lockdown measures during the “golden month.”

The global impact of COVID-19The novel coronavirus SARS-COV-2 (COVID-19) was first reported in December 2019 with the first patient hospitalized in the city of Wuhan, China (Wu et al. 2020). By mid-March 2020 the outbreak affected over 190 countries with over 450,000 cases and over 20,000 deaths, thus being declared a pandemic and a global public health emergency by the World Health Organization (2020). On January 24, 2020 Europe reported its first case followed by a case in the United Kingdom (UK) 5 days later (Spiteri et al. 2020). Such a pandemic is an unprecedented event, and governments have had to enact firm social distancing and lockdown measures in an attempt to mitigate further viral transmission (Anderson et al. 2020) in order to reduce morbidity and mortality.British response to the pandemicThe English government responded by implementing social distancing measures on the March 16, 2020 in an attempt to reduce the rate of transmission and therefore the demands on the National Health Service (UK Government 2020a). This was followed a week later by more stringent measures, commonly referred to as a societal “lockdown” (UK Government 2020b). As of March 23, 2020, all members of the public were required to stay at home except for limited purposes and this ruling received Royal Assent by March 26 within the rest of the UK. Furthermore, all public gatherings of more than 2 people and non-essential businesses were suspended. In response to the NHS emergency declaration (National Health Service England 2020), the Royal College of Surgeons (2020) and the British Orthopaedic Association (2020) both issued statements and guidelines for delivering emergency trauma and orthopedic care during the COVID-19 outbreak. The phenomenon of a reduction in trauma burden due to such social distancing measures has been described by Stinner et al. (2020), as well as the potential impact of COVID-19 on operative capacity and pathways. There has been little to explore on how COVID-19 affects the etiology of trauma referral workloads and the operative casemix.We evaluated the impact of the COVID-19 pandemic at a central London level 1 trauma center, also known as a Major Trauma Centre (MTC), evaluating the trends of acute orthopedic trauma referral caseload and operative casemix before (2019) and during (2020) the COVID-19 lockdown (i.e., the “golden” month period starting from March 17).    相似文献   
45.
International Journal of Mental Health and Addiction - The present study sought to examine optimism and hope as predictors of suicidal behaviors (viz., suicide ideation and suicide attempt) in a...  相似文献   
46.
47.
股骨头坏死的发病机理尚未明确,从多角度探讨其发病机理,以期为多样化治疗提供依据成为当今医者不断追求的目标。中医体质学认为,不同体质类型对不同疾病的发生具有倾向性。本文从股骨头坏死高发中医体质类型血瘀质入手,对其与股骨头坏死相关性进行探析,为中医调体干预股骨头坏死中早期治疗提供新思路。  相似文献   
48.
49.
50.
BackgroundSeveral neuroablative procedures are available for severe and treatment-resistant obsessive–compulsive disorder (OCD), but limited knowledge about their relative clinical advantages and disadvantages poses obstacles for treatment decision-making.MethodsWe searched PubMed, Embase, Scopus, Web of Knowledge and the Cochrane Library for reports up to February 2019. We reviewed the literature on the effectiveness (assessed using the Yale–Brown Obsessive Compulsive Scale [Y-BOCS]) and safety of various neuroablative interventions for severe and treatment-resistant OCD.ResultsWe included 23 studies involving 487 patients in the systematic review; 21 studies with 459 patients were included in the meta-analysis. Overall, neuroablation achieved a response rate (proportion of patients with ≥ 35% reduction in Y-BOCS) of 55%. Most of the adverse events (88.4%) were mild and transient. The top 3 adverse events were headache (14.9%), cognitive deficits (9.1%) and behaviour problems (8.1%). Severe or permanent adverse events included personality changes (2.3%) and brain edema or brain cyst (1.5%). The response rates associated with capsulotomy, limbic leucotomy and cingulotomy were 59% (95% confidence interval [CI] 54–65), 47% (95% CI 23–72) and 36% (95% CI 23–50), respectively. Interventions with different coverages of the dorsal part of the internal capsule were associated with different adverse-event profiles but were unlikely to modify clinical effectiveness.LimitationsThe level of evidence of most included studies was relatively low.ConclusionAblative surgeries are safe and effective for a large proportion of patients with severe and treatment-resistant OCD. Among the available procedures, capsulotomy seemed to be the most effective. Further research is needed to improve clinical effectiveness and minimize risks.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号